TransUnion (TRU) Sells TransUnion Healthcare to Clearlake Capital's nThrive for $1.7B

Go back to TransUnion (TRU) Sells TransUnion Healthcare to Clearlake Capital's nThrive for $1.7B

TransUnion (TRU) PT Raised to $143 at Goldman Sachs

October 26, 2021 4:16 PM EDT

Goldman Sachs analyst George K. Tong raised the price target on TransUnion (NYSE: TRU) to $143.00 (from $140.00) while maintaining a Buy rating.

... More

TransUnion (TRU) to Sell TransUnion Healthcare to Clearlake Capital Group-Backed nThrive for $1.7 Billion

October 26, 2021 6:16 AM EDT

TransUnion (NYSE: TRU) has signed a definitive agreement to sell TransUnion Healthcare, Inc. (TransUnion Healthcare) to nThrive, Inc. (nThrive), a leading healthcare revenue cycle management (RCM) software-as-a-service (SaaS) platform backed by Clearlake Capital Group, L.P. (together with certain affiliates, Clearlake).

The transaction consideration is $1.735 billion in cash, and the transaction is expected to result in approximately $1.4 billion in after-tax proceeds at current tax... More

TransUnion (TRU) Acquires Sontiq for $638M

October 26, 2021 6:14 AM EDT

TransUnion (NYSE: TRU) has signed a definitive agreement to acquire Sontiq, a leader in digital identity protection and security. Sontiq provides solutions to empower consumers and businesses to proactively protect against identity theft and cyber threats, including identity monitoring, restoration, and response products and services. Sontiqs focus on identity security complements TransUnions digital identity assets and solutions, and the combined company will offer a comprehensive set of omnichannel solutions to make trust possible for consumers and businesses.

Headquartered in Nottingham, Md., Sontiq is expected to generate approximately $85 million of revenue in 2021,... More